Ra Capital Management, L.P.

EDGAR CIK 0001346824

Mineralys Therapeutics, Inc. - MLYS

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$17.50 M
1,296,296 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/13/2025
03/17/2025
Buy
1,296,296 @ $13.50
 $17,499,996 4,280,051 (43.45%) Indirect - See footnotes

Janux Therapeutics, Inc. - JANX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
4
$79.04 M
2,024,041 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/07/2025
03/07/2025
Buy
110,206 @ $31.02
 $3,418,590 10,141,287 (1.10%) Indirect - See footnotes
03/06/2025
03/07/2025
Buy
372,093 @ $30.78
 $11,453,023 10,031,081 (3.85%) Indirect - See footnotes
03/05/2025
03/07/2025
Buy
341,742 @ $30.64
 $10,471,352 9,658,988 (3.67%) Indirect - See footnotes
10/18/2024
10/22/2024
Buy
1,200,000 @ $44.75
 $53,700,000 9,317,246 (14.78%) Indirect - See footnotes

89Bio, Inc. - ETNB

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$50.00 M
5,714,285 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/30/2025
02/03/2025
Buy
5,714,285 @ $8.75
 $49,999,994 19,554,319 (41.29%) Indirect - See Footnotes

Tyra Biosciences, Inc. - TYRA

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$19.84 M
1,220,681 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
11/08/2024
11/13/2024
Buy
1,220,681 @ $16.25
 $19,836,066 8,697,956 (16.33%) Indirect - See footnotes

An2 Therapeutics, Inc. - ANTX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
1
($3.81) M
-3,525,094 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
08/09/2024
08/13/2024
Sell
-3,525,094 @ $1.08
 ($3,807,102) 300,853 (-92.14%) Indirect - See footnotes

Climb Bio, Inc. - CLYM

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$49.95 M
13,008,546 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/27/2024
07/01/2024
Buy
13,008,546 @ $3.84
 $49,952,817 2,866,375 (-128.26%) Indirect - See footnotes

Aerovate Therapeutics, Inc. - AVTE

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$1.55 M
928,110 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/17/2024
06/20/2024
Buy
928,110 @ $1.67
 $1,549,944 7,893,678 (13.32%) Indirect - See footnotes